Sonja Schmid

发表

Precursor lesions in patients with multiple endocrine neoplasia type 1-associated duodenal gastrinomas.

G. Klöppel, P. Komminoth, P. Saremaslani, 2005, Gastroenterology.

Chromosomal instability predicts metastatic disease in patients with insulinomas.

P. Komminoth, S. Claessen, A. Perren, 2005, Endocrine-related cancer.

Absence of BRAF gene mutations differentiates spitz nevi from malignant melanoma.

P. Komminoth, P. Saremaslani, P. Heitz, 2004, Anticancer research.

Putative tumor suppressor loci at 6q22 and 6q23-q24 are involved in the malignant progression of sporadic endocrine pancreatic tumors.

E. Speel, P. Komminoth, P. Saremaslani, 2001, The American journal of pathology.

Islet 1 (Isl1) Expression is a Reliable Marker for Pancreatic Endocrine Tumors and Their Metastases

H. Moch, P. Komminoth, P. Heitz, 2008, The American journal of surgical pathology.

WHO 2004 Criteria and CK19 are Reliable Prognostic Markers in Pancreatic Endocrine Tumors

N. Probst-Hensch, H. Moch, V. Rousson, 2007, The American journal of surgical pathology.

No mutations but an increased frequency of SDHx polymorphisms in patients with sporadic and familial medullary thyroid carcinoma.

M. Montani, P. Komminoth, P. Saremaslani, 2005, Endocrine-related cancer.

Candidate gene mutation analysis in bilateral adrenal pheochromocytoma and sympathetic paraganglioma.

W. Dinjens, E. Korpershoek, R. D. de Krijger, 2007, Endocrine-related cancer.

BRAF and endocrine tumors: mutations are frequent in papillary thyroid carcinomas, rare in endocrine tumors of the gastrointestinal tract and not detected in other endocrine tumors.

P. Komminoth, P. Saremaslani, P. Heitz, 2004, Endocrine-related cancer.